http://www.law360.com/ Latest articles for organization: CVS Copyright 2009 Portfolio Media, Inc. en-US http://www.law360.com/images/headings/logo.gif http://www.law360.com/ http://www.law360.com/articles/132917 The Federal Trade Commission has launched a probe of CVS Caremark Corp., raising questions about the focus of the investigation given recent complaints from lawmakers, unions and community drugstores that the 2007 merger of the drugstore giant with a pharmacy benefits manager has curbed competition. http://www.law360.com/articles/132917 http://www.law360.com/articles/131954 Consumers have hit Target Corp., CVS Caremark Corp., Wal-Mart Stores Inc. and several others with a putative class action alleging that the companies made misleading claims about the effectiveness of weight-loss product Relacore or sold the product knowing it was "worthless." http://www.law360.com/articles/131954 http://www.law360.com/articles/131711 A group of consumers has asked a federal judge to certify three classes — each of which would purportedly consist of at least 10,000 people — in a lawsuit accusing Wal-Mart Stores Inc., Zoller Laboratories LLC and others of making fraudulent claims about weight loss products Zantrex-3 and Akavar 20/50. http://www.law360.com/articles/131711 http://www.law360.com/articles/131839 The U.S. Supreme Court has declined to hear Internet pharmacy Rx.com Inc.'s challenge to the dismissal of its case accusing pharmacy benefit managers Caremark Rx Inc., Medco Health Solutions Inc. and Express Scripts Inc. of violating the Sherman Act by instituting a group boycott. http://www.law360.com/articles/131839 http://www.law360.com/articles/128284 A federal judge has given the initial green light to O'Neal Inc., former Revco DS Inc. unit Retrac Inc. and several of their insurers for a settlement of up to $110 million in a class action over E-Ferol, a toxic vitamin solution manufactured by Retrac's predecessor and given to premature infants in the mid-1980s. http://www.law360.com/articles/128284 http://www.law360.com/articles/127375 Rite Aid Corp. has moved to dismiss a putative overtime class action filed by a former drugstore employee, saying it is identical to another class action filed earlier. http://www.law360.com/articles/127375 http://www.law360.com/articles/126973 Creditors have pelted Hayes Lemmerz International Inc. with objections to a broadly supported amended plan of reorganization they say is amiss, not least because the bankrupt wheel maker failed to obtain consent from certain lenders before arranging debtor-in-possession financing. http://www.law360.com/articles/126973 http://www.law360.com/articles/125913 TQP Development LLC has dropped ING Groep NV from an ongoing patent infringement lawsuit accusing a slew of major companies — including Ticketmaster Entertainment Inc. MetLife Inc., Apple Inc. and eBay Inc. — of infringing its online encrypted data transmission method. http://www.law360.com/articles/125913 http://www.law360.com/articles/124772 Plaintiffs are seeking to obtain class status in a multidistrict litigation accusing Pfizer Inc. and its Warner-Lambert Co. subsidiary of using patent litigation to postpone generic competition for epilepsy treatment Neurontin. http://www.law360.com/articles/124772 http://www.law360.com/articles/124806 CVS Pharmacy Inc., Walgreen Co., Wal-Mart Stores Inc. and others have asked a judge to dismiss a proposed class action accusing them of overcharging for generic drugs by not passing along discounts to consumers. http://www.law360.com/articles/124806 http://www.law360.com/articles/123965 Should the Federal Trade Commission take heed of pressure to begin a new review of the 2007 deal that created CVS Caremark Corp., it would be just the latest in an increasing number of deals to receive post-consummation review. http://www.law360.com/articles/123965 http://www.law360.com/articles/122793 Ticketmaster Entertainment Inc., Apple Inc. and Exxon Mobil Corp. are among a slew of major companies that have been sued by TQP Development LLC, alleging infringement of a patent related to an online encrypted data transmission method. http://www.law360.com/articles/122793 http://www.law360.com/articles/122376 Eight members of Congress — four Democrats and four Republicans — have asked the Federal Trade Commission in a letter to reopen its investigation into the 2007 merger that formed CVS Caremark Corp., citing concerns about competition and consumer privacy. http://www.law360.com/articles/122376 http://www.law360.com/articles/120479 A Bronx, N.Y., former drugstore employee has filed a putative class action against Rite Aid Corp., claiming the national chain failed to pay her overtime. http://www.law360.com/articles/120479 http://www.law360.com/articles/119788 Walgreen Co., Safeway Inc. and three others have become the latest retailers to accuse Cephalon Inc. of striking illegal deals with generic-drug makers to keep a copycat version of narcolepsy drug Provigil off the market. http://www.law360.com/articles/119788 http://www.law360.com/articles/119636 Two Minnesota-based employee health funds have accused CVS Pharmacy Inc., Walgreen Co., Wal-Mart Stores Inc. and other pharmacies of overcharging customers for generic drugs, illegally hiking up prices instead of passing on the discounts they receive in the acquisition of generics to consumers. http://www.law360.com/articles/119636 http://www.law360.com/articles/119373 A federal judge has cleared the way for the multidistrict litigation alleging Pfizer Inc. and its Warner-Lambert Co. subsidiary engaged in a scheme to use patent litigation to delay generic competition for the epilepsy drug Neurontin to move forward. http://www.law360.com/articles/119373 http://www.law360.com/articles/119439 CVS Caremark Corp. has reached a confidential settlement with the two remaining plaintiffs in a wage-and-hour suit over the retailer's alleged failure to compensate pharmacy technicians for overtime, missed meal breaks, and duties performed before and after their scheduled shifts. http://www.law360.com/articles/119439 http://www.law360.com/articles/117786 A federal appeals court has rejected a bid for an en banc rehearing of its decision to limit a settlement to $10 million in a class action alleging that Abbott Laboratories illegally jacked up the prices of its market-dominating HIV drug Norvir, sticking to its finding that the plaintiffs failed to state a claim in light of recent case law. http://www.law360.com/articles/117786 http://www.law360.com/articles/117921 A magistrate judge has tossed a proposed class action seeking more than $5 million from CVS Pharmacy for allegedly selling eyeglass repair kits labeled “Made in USA” that were actually manufactured using imported parts. http://www.law360.com/articles/117921